Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
acid, aggressive, Agriculture, alanine, ALT, aminotransferase, AMP, AnaptysBio, antisense, apparent, arthropathy, ASCO, ASP, aspartate, AST, asthenia, auditor, BA, basal, Bavencio, BCC, BCMA, begun, bempedoic, Biobank, BSC, Budgetary, bundled, cap, capped, Cardiology, ceiling, cemiplimab, cervical, cGCP, checkpoint, Chimie, christopher, CJSC, clarification, Coast, cohort, combat, companion, complement, compromised, conjugated, consortium, conventional, COPD, correlated, count, CSA, CSCC, cutoff, daily, DCR, Decibel, depot, Dermira, diagnostic, disproportionate, distantly, divisional, DOR, durable, Dysphagia, EEsAI, en, evade, exome, eyelid, fenimore, forward, FSS, gap, Gastroenterology, GBM, GDPR, Genzyme, Gilead, GILTI, glioblastoma, Graybug, GSK, Guaranty, Guard, heterotopic, hierarchical, histopathologic, ICS, illegitimate, Imfinzi, immunotherapy, inadvisable, inappropriate, inclisiran, ineffective, infarction, inoperable, Inovio, Instrument, intraepithelial, IPR, ISA, Keytruda, kinase, LCA, led, LEO, licensure, light, maculopapular, manifested, median, methodology, military, misrepresentation, Momenta, mucin, multiforme, Mylan, myocardial, naproxen, needy, notional, NSCLC, null, OCS, ointment, Olumiant, Opdivo, Opthea, orderly, ORR, ossification, OTA, panel, parent, payor, PCAOB, peak, plaintiff, poorer, potently, pulmonary, put, RCC, readily, refinance, refractory, refrigeration, regular, rehearing, remanded, renal, reopen, repair, replicated, resorting, restore, retail, revascularization, Samsung, SDI, sentence, shutdown, SillaJen, speculative, Straumann, subgroup, subleased, sunitinib, suptavumab, suspect, swap, Symptom, Tecentriq, TESARO, Tokyo, tracing, TRACON, tralokinumab, TRAVERSE, TriCare, Trump, Tyrogenex, tyrosine, unaudited, unresectable, unwilling, upadacitinib, upward, Urban, vacated, vaccinia, vast, vehicle, VENTURE, void, volunteer, waive, younger
Removed:
accumulate, accurate, acknowledged, ACR, acuity, adalimumab, AEs, affinity, alleging, amortize, anacetrapib, Antitrust, Asia, Assistant, assure, autoimmunity, Avalanche, Bispecific, blended, blockage, bloodstream, branching, branded, Brazil, capitalizing, CATT, centrally, CETP, cholesterylester, clearing, College, combine, composed, conditional, constructed, constructing, contamination, deductible, dosed, draining, driven, EASI, element, emergency, Endothelial, estate, exceeded, executing, exemption, exercising, expiring, fluid, gastrointestinal, GlaxoSmithKline, headache, history, Hope, host, idiopathic, IGA, imputed, incremental, indexed, interference, invented, investing, iso, Israel, Johnson, juvenile, label, Labour, launching, leakage, longest, main, mccorkle, mediate, mediated, month, myostatin, naturally, notified, obstruction, occupancy, ophthalmic, ordinary, organism, overactive, oversee, participate, partner, PDGF, peptide, permeability, PharmD, prohibited, proliferation, prompt, real, reformed, released, releasing, renovating, repay, replacement, requested, reside, Rheumatology, rolled, Scarring, skin, SOLO, subcutaneously, supporting, tenant, termed, thirty, timeline, tract, travel, Treasurer, uncommon, upcoming, upper, vascular, Western, white
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2.11 Stock Option Agreement and Notice of Grant (NQ) to Executive Officers
- 10.2.12 Stock Option Agreement and Notice of Grant (Iso) to Executive Officers
- 10.2.13 Stock Option Agreement and Notice of Grant (NQ) to P. Roy Vagelos
- 10.2.14 Stock Option Agreement and Notice of Grant (Iso) to P. Roy Vagelos
- 10.2.15 Restricted Stock Award Agreement and Notice of Grant to Executive Officers
- 10.2.16 Stock Option Agreement and Notice of Grant (NQ) to Non-employee Directors
- 21.1 Subsidiaries of Regeneron Pharmaceuticals, Inc.
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)
- 32 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
Associated REGN transcripts
REGN similar filings
Filing view
External links